UTI & Drug Resistance Gene Panel – 31
This PCR panel detects 31 analytes from a single urine sample — 19 urinary-tract pathogens plus 12 antibiotic-resistance genes. It identifies infections faster and more accurately than traditional culture, and flags resistance before treatment starts.
2 to 3 days
Turnaround
Urine
Sample
What the UTI & Drug Resistance Gene Panel – 31 test tells you
This urinary tract panel is a molecular test performed on a single urine sample. It searches for the genetic material of a wide group of organisms that cause urinary infection, and at the same time for a set of genes that bacteria use to defend themselves against antibiotics. Because it looks for DNA rather than waiting for bacteria to grow, it can identify organisms that culture struggles with — those that grow slowly, need unusual conditions, or have already been suppressed by an antibiotic the patient started before the sample was taken.
The resistance component covers the gene families that matter most in practice: the carbapenemases blaIMP, blaKPC, blaNDM, blaOXA-48 and blaVIM, the extended-spectrum beta-lactamase gene CTX-M, the methicillin resistance gene mecA, the sulfonamide resistance genes suL1, suL2 and suL3, and the vancomycin resistance genes vanA and vanB. Finding one of these tells your doctor that a mechanism capable of defeating a particular class of antibiotic is present in the sample, which is useful information early — long before a culture would have reported it.
This information supports a prescribing decision; it does not make one. Detecting a resistance gene is not the same as proving that the organism causing your infection is resistant in practice: when several bacteria are present, the gene cannot be assigned with certainty to any one of them, and a gene can be carried without being expressed. For the same reason this panel does not replace urine culture and sensitivity testing, which measures how the specific organism actually behaves against specific antibiotics. Which antibiotic to use, at what dose and for how long, remains a decision for the doctor treating you, taking the panel, the culture, your kidney function and your history together.
Recommended for recurrent UTIs, culture-negative UTIs with persistent symptoms, complicated UTIs, infections that have already failed a course of antibiotics, and when rapid identification of both the organism and its resistance profile is needed.
Slow-growing and fastidious bacteria that fail to appear on a culture plate can still be identified by their genetic material.
Resistance genes are reported alongside the organisms, giving your doctor a head start on which antibiotic classes are unlikely to work.
When symptoms keep returning or cultures keep coming back negative, a molecular panel often explains what has been going on.
More than one organism can be present at once, and the panel reports each one rather than only whichever grows fastest.
Reasons your doctor may request the UTI & Drug Resistance Gene Panel – 31 test
Your doctor may order this test for any of the reasons below. Some are routine checks, others follow specific symptoms or an earlier result.
Symptoms that persist or keep returning
Urinary symptoms that keep returning after apparently successful treatment.
Persistent burning, urgency or lower abdominal discomfort with a negative urine culture.
Infections that have not responded
A urinary infection that has not responded to a completed course of antibiotics.
Urinary infection in someone with a history of resistant organisms or recent hospital care.
Complicated infection & rapid identification
Complicated infection in pregnancy, diabetes, kidney stones or an indwelling catheter.
Suspected infection where a rapid identification of the organism and its resistance profile would change management.
No fasting window — pick any slot that suits you, online or on WhatsApp.
A DHA-licensed nurse collects your sample at home or in the office — free home collection.
A physician-reviewed, easy-to-read report lands securely by WhatsApp and email.
A PCR panel for urinary-tract pathogens and antibiotic-resistance genes.
UTI & Drug Resistance Gene Panel – 31
A PCR panel for urinary-tract pathogens and antibiotic-resistance genes.
None of the panel targets were detected — a negative result.
One or more targets were detected. Your report lists which one(s); please consult your physician.
This test is reported descriptively rather than on a numeric scale — each finding below explains what your report may say.
This information is for general education only and is not medical advice. Reference ranges can vary by laboratory, age, sex, and individual factors. Always consult your physician or doctor to interpret your results.
What a higher result can point to
- Active urinary tract infection by one or more of the organisms covered by the panel.
- A mixed infection involving several organisms, which culture may under-report.
- Colonisation of the bladder or catheter without true infection, particularly in older adults and catheter users.
- Residual bacterial DNA from an infection that has recently been treated.
- Contamination of the sample by organisms from the skin or genital area during collection.
- Presence of a resistance gene in the sample, indicating a defence mechanism against a class of antibiotics.
These are possibilities, not diagnoses. A single value outside the reference range is interpreted alongside your symptoms, history and other tests — your doctor decides what it means for you.
What this test cannot tell you
- Detecting bacterial DNA does not prove active infection, since organisms can colonise the urinary tract or a catheter without causing illness.
- A resistance gene found in the sample cannot always be attributed to the specific organism causing your infection, and a gene that is present is not always active.
- The panel does not replace urine culture and sensitivity testing, which measures how the isolated organism actually responds to individual antibiotics.
- Genetic material can persist after treatment, so the panel is not a reliable test of cure.
Risks of the blood draw
- Mild bruising or brief soreness where the needle went in.
- Occasional lightheadedness, which settles after a few minutes of rest.
- Bleeding or infection at the site, which is rare with sterile single-use equipment.
- 1One urine sample is examined for a broad group of urinary organisms and for antibiotic resistance genes.
- 2It is more sensitive than culture for organisms that grow poorly or have been partly suppressed by antibiotics.
- 3Resistance genes give early guidance but are not a substitute for culture and sensitivity testing.
- 4Results are interpreted with your symptoms, because bacteria in the urine do not always mean infection.
- 5Antibiotic choice is always a prescribing decision made by your treating doctor.
Frequently Asked Questions
Everything you need to know about the UTI & Drug Resistance Gene Panel – 31 test. Can't find what you're looking for?
Talk to our team→Often yes. Culture depends on bacteria surviving transport and growing on a plate, and several organisms that cause urinary symptoms grow slowly or need conditions a routine culture does not provide. A molecular panel looks for their genetic material instead, so it can identify a cause when culture has repeatedly reported nothing.
Not necessarily. The panel reports that a resistance mechanism is present somewhere in the sample. It cannot always tell which organism is carrying it, and a gene that is present is not always switched on. The finding is an early warning that helps your doctor choose more carefully, and it is weighed against the culture and sensitivity result rather than replacing it.
No. Bacteria can live in the bladder, and especially on a catheter, without causing illness, and treating that situation often does more harm than good. Your doctor decides on treatment by combining the panel with your symptoms, your examination and your circumstances, rather than treating the report alone.
It is not well suited to that. Bacterial genetic material can remain detectable for a period after the living organisms have gone, so a repeat panel soon after treatment may still be positive even when the infection has resolved. Whether you are better is judged mainly on symptoms, with culture used when a test of cure is genuinely needed.
This PCR panel detects 31 analytes from a single urine sample — 19 urinary-tract pathogens plus 12 antibiotic-resistance genes. It identifies infections faster and more accurately than traditional culture, and flags resistance before treatment starts.
Recommended for recurrent UTIs, culture-negative UTIs with persistent symptoms, complicated UTIs, and when rapid identification of the causative organism is needed.
No, fasting is not required for the UTI & Drug Resistance Gene Panel (31) test, so you can eat and drink normally beforehand.
The UTI & Drug Resistance Gene Panel (31) test uses a urine sample, collected quickly by our DHA-licensed phlebotomist with minimal discomfort.
Results for the UTI & Drug Resistance Gene Panel (31) test are typically ready within 2 to 3 days. You will receive a secure digital report, and your Smart Report highlights anything outside the normal range.
The UTI & Drug Resistance Gene Panel (31) test is AED 619, which includes free home sample collection and a physician-reviewed report. You can also build a custom panel and pay only for the markers you choose.
Yes. A DHA-licensed phlebotomist can collect your sample at home or the office anywhere in Dubai at no extra cost, 7 days a week. See how it works.
It is commonly chosen by all ages. If you are not sure it is right for you, our care team is happy to advise.
Add the UTI & Drug Resistance Gene Panel (31) test to your cart and complete the short booking wizard, choosing home collection or a lab visit. Guest checkout lets you book without creating an account.
Yes. It is processed at our EIAC-accredited laboratory (ISO 15189:2022) under DHA license 0046381 and verified by board-certified pathologists.
Every report includes reference ranges and plain-language notes. If you have questions, our care team can arrange a clinician review — just get in touch.
Absolutely. Add it to a curated health package or bundle it with any of our 160+ biomarkers, often from a single sample in one visit.